Video Credit: Reuters Studio - Duration: 01:24s - Published
Vaccine manufacturing is lumpy, UK says
Britain's vaccine rollout is limited by a "lumpy" manufacturing process with production changes by Pfizer and a delay by AstraZeneca that could lead to brief supply disruption, Vaccine Deployment Minister Nadhim Zahawi said on Monday.
Vaccines minister Nadhim Zahawi said authorities are working with the postal service to locate a person infected with a concerning variant of coronavirus first found in Brazil. It is thought the person was tested on February 12 or 13, possibly via a home postal test or a test collected from a local authority. The vaccines minister urged anyone tested within this time who has not had a result back, to contact 119. Report by Thomasl. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
Speaking on BBC Breakfast, vaccines minister Nadhim Zahawi appeals for help to trace one of six people infected with the new Brazilian variant of the virus.
Credit: PA - Press Association STUDIO Duration: 00:59Published
British Vaccine Minister Nadim Zahawi and Israeli Covid-19 advisor Ran Balicer discuss lessons learned from their successful coronavirus vaccine launches.
Vaccines Minister Nadhim Zahawi sets out the role that the Covid vaccine deployment will play in the wider context of exiting from the national lockdown. Prime Minister Boris Johnson will announce the roadmap out of current restrictions on Monday afternoon. Report by Jonesia. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
The current national coronavirus lockdown should be England’s last, a government minister has said.Vaccines minister Nadhim Zahawi said there shouldn’t be a need for another nationwide lockdown if this one is eased cautiously.His comments came as prime minister Boris Johnson prepares to unveil his plan later on Monday for exiting the lockdown.Credit: Sky News via Twitter
Initial deliveries of the newly approved Johnson & Johnson COVID-19 vaccine should start on Tuesday, senior Biden administration officials said on Sunday, saying they hoped to boost lagging vaccination rates among minorities. Bryan Wood reports.
[NFA] Dr. Anthony Fauci, the top U.S. infectious disease official, on Sunday urged Americans to take any of the three approved COVID-19 vaccines available to them, including the newly-authorized single-shot vaccine from Johnson & Johnson. Lisa Bernhard produced this report.
A single dose of the Pfizer-BioNTech coronavirus vaccine reduces the risk of asymptomatic infections, helping to stem transmission, research suggests.The UK has approved three coronavirus jabs – Pfizer-BioNTech, AstraZeneca-University of Oxford and Moderna – after studies demonstrated they significantly ward off severe disease.With not everyone able to be immunised, or producing a strong immune response as a result of their vaccination, questions lingered as to whether the jabs prevented the infection itself.Asymptomatic infections are particularly important amid the pandemic, given these individuals do not know to isolate and may unwittingly transmit the coronavirus even when they speak.To learn more, medics from the Cambridge University Hospitals NHS Foundation Trust (CUH) swabbed the site's vaccinated and unvaccinated healthcare workers over two weeks.Results suggest the risk of an asymptomatic infection decreases by four times more than 12 days after a worker received the Pfizer-BioNTech jab.
After Canada approved AstraZeneca’s Covid-19 vaccine, 500,000 doses of the same vaccine manufactured in India will arrive in Canada on Wednesday. Canadian.. IndiaTimes
Guatemala President Alejandro Giammattei thanked Prime Minister Narendra Modi and External Affairs Minister S Jaishankar for donating 2,00,000 doses of Covishield vaccines. President Alejandro Giammattei said, "I would like to start by thanking Prime Minister of India, Mr. Narendra Modi, and External Affairs Minister S Jaishankar for accepting our call for assistance in supply of Covishield vaccines manufactured in India under licensing of Astra Zeneca. It has been a grand surprise for us to know that India rather than selling the vaccines to us, it has immediately donated to us 200 thousand doses that will help to immunise frontline, health workers."
Canada on Friday approved AstraZeneca's COVID-19 vaccine, including the version produced by the Serum Institute of India, and 500,000 doses are due to arrive next week.